Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BioNTech Faces NIH Heat: Notice of Default Issued Over COVID-19 Vaccine Royalties | Contract Pharma

What are you searching for?

Sign in
Breaking News

BioNTech Faces NIH Heat: Notice of Default Issued Over COVID-19 Vaccine Royalties

BioNTech intends to defend itself against all allegations of breach.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

On March 22, 2024, BioNTech SE, which recently named a new CCO, received a notice of default from the NIH concerning royalties and other amounts allegedly owed on sales of the company’s COVID-19 vaccine since commercialization.
 
A notice of default from the National Institutes of Health (NIH) is a legal step taken against a party that the NIH believes has failed to meet its obligations under a licensing agreement.
 
BioNTech says it “disagrees with the positions being taken by the NIH and intends to vigorously defend itself against all allegations of breach.”

More BioNTech News

BioNTech and Autolus Therapeutics recently announced a strategic collaboration aimed at advancing both companies’ autologous CAR-T programs toward commercialization, pending regulatory authorizations.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics